Health Costs

  • Your Selections:

Refine Results

date

Topics

Content Type

Tags

Public Opinion on Prescription Drugs and Their Prices

This charticle draws on recent KFF poll findings to provide an in-depth look at the public’s attitudes toward prescription drugs and their prices. Results include Americans’ opinions on drug affordability, pharmaceutical companies, and various potential measures that could lower prices.

Insurer Filings Suggest COVID-19 Pandemic Will Not Drive Health Spending In 2022

This brief reviews initial 2022 premium rate filings for Marketplace-participating individual market insurers in 13 states and the District of Columbia. Most expect health utilization patterns to return to pre-pandemic levels and therefore not factoring in any impact on their 2022 premiums.

KFF Health Tracking Poll – October 2021: Home And Community Based Services And Seniors’ Health Care Needs

The October KFF Health Tracking Poll explores experiences with unpaid caregiving, and favorability of expansion of home and community based services (HCBS). It also examines experiences with difficulty affording and putting of health care services among seniors, favorability of the ACA and experience with determining eligibility for lower cost insurance as part of the COVID relief package.

COVID-19 continues to be a leading cause of death in the U.S. in September 2021

This updated analysis finds that in September 2021, COVID-19 ranked as the 2nd leading causes of death in the U.S., up from 8th in July, due to the more infectious Delta variant, insufficient vaccination, and reduced social distancing. An estimated 90,000 deaths from COVID-19 since June could have been prevented with vaccines.

The Public Weighs In On Medicare Drug Negotiations

This data note from the latest KFF Health Tracking Poll explores the public’s views on Medicare drug price negotiation, including how arguments on both sides impact support and opposition; confidence in leaders to do the right thing on drug pricing; and experiences with prescription drug costs.

How Marketplace Costs and Premiums Will Change if American Rescue Plan Subsidies Expire

In a new Policy Watch, KFF analysts explore the potential impact of the expiration of the American Rescue Plan Act’s enhanced financial help and new eligibility for the Affordable Care Act’s health insurance Marketplace federal subsidies. While the COVID-19 relief legislation passed earlier this year provides greater subsidy assistance through…

How Marketplace Costs and Premiums will Change if Rescue Plan Subsidies Expire

In this Policy Watch we explore the potential impact of the expiration of the American Rescue Plan Act’s enhanced financial help and new eligibility for the Affordable Care Act’s health insurance Marketplace federal subsidies. While the COVID-19 relief legislation passed earlier this year provides greater subsidy assistance through 2022, Democrats in Congress are currently considering making the temporary federal help permanent or extending it as part of their planned budget reconciliation legislation.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.